Page 17 - 16Neonatal Jaundice_compressed
P. 17

Guidance summary





              ID        Recommendations                                                 See Chapter/Section
                        Phototherapy equipment

              42        Ensure all phototherapy equipment is maintained and used according to          7.2.1
                        the manufacturers’ guidelines.
              43        Use incubators or bassinets according to clinical need and availability.       7.2.4
              44        Do not use white curtains routinely with phototherapy as they may impair       7.2.4
                        observation of the baby.
                        Factors that influence the risk of kernicterus
              45        Identify babies with hyperbilirubinaemia as being at increased risk of           3.2
                        developing kernicterus if they have any of the following:
                        •   a serum bilirubin level greater than 340 micromol/litre in babies with a
                          gestational age of 37 weeks or more
                        •   a rapidly rising bilirubin level of greater than 8.5 micromol/litre per
                          hour
                        •   clinical features of acute bilirubin encephalopathy.
                        Formal assessment for underlying disease

              46        In addition to a full clinical examination by a suitably trained healthcare      6.1
                        professional, carry out all of the following tests in babies with significant
                        hyperbilirubinaemia as part of an assessment for underlying disease (see
                        threshold table (Section 1.3) and treatment threshold graphs (Section 1.6)):
                        •   serum bilirubin (for baseline level to assess response to treatment)
                        •   blood packed cell volume
                        •   blood group (mother and baby)
                        •   DAT (Coombs’ test). Interpret the result taking account of the strength of
                          reaction, and whether mother received prophylactic anti-D
                          immunoglobulin during pregnancy.
              47        When assessing the baby for underlying disease consider whether the              6.1
                        following tests are clinically indicated:
                        •   full blood count and examination of blood film
                        •   blood glucose-6-phosphate dehydrogenase levels, taking account of
                          ethnic origin
                        •   microbiological cultures of blood, urine and/or cerebrospinal fluid (if
                          infection is suspected).

                        Care of babies with prolonged jaundice
              48        In babies with a gestational age of 37 weeks or more with jaundice lasting       6.2
                        more than 14 days, and in babies with a gestational age of less than
                        37 weeks with jaundice lasting more than 21 days:
                        •   look for pale chalky stools and/or dark urine that stains the nappy
                        •   measure the conjugated bilirubin
                        •   carry out a full blood count
                        •   carry out a blood group determination (mother and baby) and DAT
                          (Coombs’ test). Interpret the result taking account of the strength of
                          reaction, and whether mother received prophylactic anti-D
                          immunoglobulin during pregnancy.
                        •   carry out a urine culture
                        •   ensure that routine metabolic screening (including screening for
                          congenital hypothyroidism) has been performed.






                                                                                                          9
   12   13   14   15   16   17   18   19   20   21   22